29571-44-6

Basic information

• Product Name: 5-PYRIMIDINEACETIC ACID, 3,4-DIHYDRO-2-(METHYLTHIO)-4-OXO-, ETHYL ESTER
• Synonyms: 5-PYRIMIDINEACETIC ACID, 3,4-DIHYDRO-2-(METHYLTHIO)-4-OXO-, ETHYL ESTER;ethyl 2-(4-hydroxy-2-(Methylthio)pyriMidin-5-yl)acetate;ETHYL 2-(2-(METHYLTHIO)-6-OXO-1,6-DIHYDROPYRIMIDIN-5-YL)ACETATE;4-Hydroxy-2-(methylthio)-5-pyrimidineacetic acid ethyl ester;NSC 165311;3,4-DIHYDRO-2-(METHYLTHIO)-4-OXO-5-PYRIMIDINEACETIC ACID ETHYL ESTER;Ethyl 2-(4-Hydroxy-2-(Methylthio)Pyrimidin-5-Yl)Acetate(WX618475)
• CAS NO: 29571-44-6
• Molecular Formula: C9H12N2O3S
• Molecular Weight: 228.271
• Mol File: 29571-44-6.mol

Chemical Properties

• Melting Point: 188-189℃
• Boiling Point: 379.5°C at 760 mmHg
• Flash Point: 183.3°C
• Appearance: /
• Density: 1.32g/cm³
• Vapor Pressure: 2.67E-06mmHg at 25°C
• Refractive Index: 1.589
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-PYRIMIDINEACETIC ACID, 3,4-DIHYDRO-2-(METHYLTHIO)-4-OXO-, ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 5-PYRIMIDINEACETIC ACID, 3,4-DIHYDRO-2-(METHYLTHIO)-4-OXO-, ETHYL ESTER(29571-44-6)
• EPA Substance Registry System: 5-PYRIMIDINEACETIC ACID, 3,4-DIHYDRO-2-(METHYLTHIO)-4-OXO-, ETHYL ESTER(29571-44-6)

Safety Data

• Hazardous Substances Data: 29571-44-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5-Pyrimidineacetic acid, 3,4-dihydro-2-(methylthio)-4-oxo-, ethyl ester is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique structure with a pyrimidine ring, ketone, and thioether group may contribute to the development of new therapeutic agents with novel mechanisms of action.
Used in Agricultural Industry:
5-Pyrimidineacetic acid, 3,4-dihydro-2-(methylthio)-4-oxo-, ethyl ester is used as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides. Its chemical properties may provide new options for controlling pests and weeds in agriculture.
Used in Research and Development:
5-Pyrimidineacetic acid, 3,4-dihydro-2-(methylthio)-4-oxo-, ethyl ester is used as a research compound for studying the properties and potential applications of pyrimidine-based compounds. Its unique structure may offer insights into the development of new chemical entities with various biological activities.

InChI:InChI=1/C9H12N2O3S/c1-3-14-7(12)4-6-5-10-9(15-2)11-8(6)13/h5H,3-4H2,1-2H3,(H,10,11,13)

Upstream product

• 147895-43-0 S-methylisothiourea hemisulphate 
• 14273-44-0 Hydroxymethylen-bernsteinsaeure-diethylester 
• 123-25-1 succinic acid diethyl ester 
• 4338-95-8 S-methylthiouronium iodide 
• 5472-38-8 diethyl 2-formylbutanedioate 

Downstream Products

• 61727-34-2 ethyl [4-chloro-2-(methylsulfanyl)pyrimidin-5-yl]acetate 

Relevant articles and documents

cGAS ANTAGONIST COMPOUNDS

Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS

The present invention is directed to heterocyclic compounds which are antagonists of CGRP receptors and may be useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Convenient synthesis of 2-substituted 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones

A new synthetic route was elaborated at our laboratory providing a convenient access to 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones (diazaoxindoles), a compound family of biological relevance. Treatment of the easily available ethyl 2-(4-chloropyrimidin-5-yl)acetate derivatives with ammonia afforded the corresponding 2-(4-aminopyrimidin-5-yl)acetamides, which were finally cyclized to the target compounds.

5,7-DIHYDRO-6H-PYRROLO[2,3-D]PYRIMIDIN-6-ONE DERIVATIVES FOR MARK INHIBITION

Compounds of formula I: are potent and selective inhibitors of microtubule affinity regulating kinase (MARK), and hence find use in treatment of Alzheimer's disease and other conditions associated with hyperphosphorylation of tau.